Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C.
about
Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferonDetection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testingQuantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infectionsStorage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virusEfficacy and side effects of intermittent recombinant interferon-alpha 2a in chronic aggressive hepatitis C: with or without initial daily administration.Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatLow-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinomaViral markers in the treatment of hepatitis B and C.Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial.Hepatitis C: progress and problems.Prediction of relapse after interferon therapy in hepatitis C virus-infected patients by the use of triple assay.The long-term efficacy of interferon alfa in chronic hepatitis C patients: a critical review.Long-term administration of natural interferon-alpha in patients with chronic hepatitis C: relationship to serum RNA concentration, HCV-RNA genotypes, histological changes and hepatitis C virus.Cold activation of complement in sera from patients with persistent hepatitis C virus infection on interferon therapy.Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C.Negative strand of hepatitis C virus RNA in the liver of patients with chronic hepatitis C after interferon treatment.Interferon therapy for 2 years or longer reduces the incidence of hepatocarcinogenesis in patients with chronic hepatitis C viral infection.Interferon treatment of two patients with quadruple infection with hepatitis C virus (HCV), human immunodeficiency virus (HIV), hepatitis G virus (HGV), and TT virus (TTV).Comparison of real-time quantitative polymerase chain reaction with three other assays for quantitation of hepatitis C virus.Comparative study of two high doses of lymphoblastoid interferon in the treatment of chronic hepatitis C: influence on the levels of ALT, viraemia and histologic activity.Factors useful in predicting the response to interferon therapy in chronic hepatitis C.Clinical usefulness of an assay for hepatitis C virus core in the diagnosis of non-A, non-B hepatitis and monitoring of the response to interferon therapy.Changes in serum levels of hepatitis C virus genotype 1b monitored by real-time quantitative polymerase chain reaction as a predictor of long term response to interferon-alpha treatment.Interferon treatment of hepatitis C: is it virological cure?Antiviral effect of lymphoblastoid interferon-alpha on hepatitis C virus in patients with chronic hepatitis type C.Genotypic subtyping of hepatitis C virus.Short and long-term effects of interferon on serum markers of hepatitis C virus replication.Long-term histological prognosis and serum fibrosis markers in chronic hepatitis C patients treated with interferon.Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2.Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study.Influence of previous interferon therapy on recurrence after resection of hepatitis c virus-related hepatocellular carcinoma.Management of chronic hepatitis C.Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single center.Psychoneurological symptoms during interferon therapy in patients with chronic hepatitis: prospective study on predictive use of Cornell Medical Index and electroencephalogram.Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.
P2860
Q27478427-2557B91C-5517-4AE9-ACBA-055AEAF5D146Q27485648-F65F626C-44EC-48CE-865D-8B764718493EQ27488242-42B6E893-2EFE-4991-B2B2-376436BD00BDQ27488873-502E2A3F-FFF5-4A4B-B4BE-47BB90C18742Q33497313-F0A8500C-315B-4AFB-9280-6AF732133F14Q34215894-8F70D51B-65B1-44F3-9595-C6FBD48D2A12Q34225588-6ACF176E-0D11-44A3-8CC6-9B8FF3BBDCCAQ34375675-46DE087A-3809-402C-B9B7-ED28FDF3677BQ34409615-C26B97C9-9F67-4CCE-AC34-45A30BE4242BQ36642065-6D3B489A-A160-46EB-B6FF-DC50D01C76E0Q38986207-34D7E73B-10F3-4A74-8F46-10623099B0D0Q40957762-3AD3EFB9-5606-4B18-A0A2-0CA13A46D3F2Q42977407-647FC3EC-C08A-49CC-ABF9-1F3ED9AD5491Q42977731-2E523D3E-C35D-458E-9370-8897CC3792CDQ42978095-D8EB4183-7D4E-4F49-96D7-4D92E58A541EQ42985954-89BB8930-78F3-4146-8A4C-F3AD97C7E4B8Q42989123-55683F4F-CDF9-4C5A-9607-630318F6ABAEQ42995643-2127FF87-43E5-4E0D-AEC6-2A52C9874AA7Q43034268-6D3163D5-F62C-4C25-AE04-BF943A0478DEQ43034948-D4A6E501-1EAA-456D-BD9A-6572692360FDQ43035328-66D6244C-1083-4CCB-8B66-0B450CBBAD51Q43036006-D09740A8-D964-4084-9FA3-8959CBC523D5Q43036784-191D7034-B499-4FB0-92C3-CC7D56D4769CQ43038924-95B7CCE2-7867-4F94-8E6A-E7BF21EDE0E9Q43042102-E1BFCBD1-0618-48BA-92F4-222AA3FE1301Q43048277-40BBEABA-79C9-4BE7-B323-63AD5B0CD067Q43048414-2EF28E2E-6433-46C5-8E82-6156DE2BDAE9Q43762372-28EAAE00-0A94-4AC9-BADA-43F1AB4E1CDFQ45402571-4235393C-9791-4B4B-8496-6529162E6FC1Q45737371-1135CFE0-9391-436B-8D79-86AD30CD7A49Q45738745-5E307EF3-A3AA-4A86-A6FB-4151ECF4D1AEQ45886289-B59DD595-6B4A-4374-83CE-297C9C892C41Q46706535-AEDDC13C-5F85-40C6-989E-24C12C73BED3Q48577589-410D057C-A733-4E5E-912D-68FDE6B9F596Q55094662-7242C528-D667-40D0-86FD-0AC9319EED55
P2860
Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Effect of interferon administr ...... ents with chronic hepatitis C.
@en
Effect of interferon administr ...... ents with chronic hepatitis C.
@nl
type
label
Effect of interferon administr ...... ents with chronic hepatitis C.
@en
Effect of interferon administr ...... ents with chronic hepatitis C.
@nl
prefLabel
Effect of interferon administr ...... ents with chronic hepatitis C.
@en
Effect of interferon administr ...... ents with chronic hepatitis C.
@nl
P2093
P1433
P1476
Effect of interferon administr ...... ents with chronic hepatitis C.
@en
P2093
Kobayashi M
Matsumoto T
Morinaga T
P304
P356
10.1016/0270-9139(91)92469-O
P407
P577
1991-06-01T00:00:00Z